.
MergerLinks Header Logo

Announced

Sulzer to acquire Haselmeier for $118m.

Financials

Edit Data
Transaction Value£90m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales2.8x
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Germany

Pending

Single Bidder

Acquisition

Private

Friendly

drug delivery devices

Medical Equipment

Majority

Synopsis

Edit

Sulzer, a Swiss industrial engineering and manufacturing firm, agreed to acquire Haselmeier, a privately held drug delivery device developer and manufacturer, for $118m. “We are excited to welcome the Haselmeier team into the APS family. Haselmeier has a successful track record of providing innovative drug delivery devices based on its proprietary IP business model. We believe that we will add to the success story by providing financial strength and precision injection molding capabilities, thereby accelerating the company’s growth. Furthermore, combining our expertise in liquid mixing applications with Haselmeier’s drug delivery competence, will benefit our pharmaceutical customers providing them with innovative and differentiated devices and services,” Girts Cimermans, Sulzer APS President.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US